INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

9865	Companies
198272	Keywords
129313	Articles
105441	Press releases

Home
Companies
INVENTIVA

BRIEF

published on 05/27/2025 at 22:05, 8 months 18 days ago

Inventiva aux Conférences Jefferies et UBS sur la Santé

Biopharmaceutique Inventiva Conférence Jefferies MASH Conférence UBS
PRESS RELEASE

published on 05/27/2025 at 22:00, 8 months 18 days ago

Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference
Inventiva to participate in Jefferies Global Healthcare Conference & UBS Spring Biotech Conference. CEO to present at fireside chat in New York City

Clinical-stage Biopharmaceutical Company Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
PRESS RELEASE

published on 05/27/2025 at 22:00, 8 months 18 days ago

Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference »
Inventiva participera à deux conférences investisseurs en juin 2025 : Jefferies Global Healthcare Conference et UBS Spring Biotech Conference. Présentation stratégique de la société et du médicament Lanifibranor

Conférences Investisseurs Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
BRIEF

published on 05/23/2025 at 08:35, 8 months 23 days ago

Inventiva Reports First Quarter 2025 Financials: Cash Position Declines

Financial Results Cash Position Clinical Trial Inventiva Lanifibranor
BRIEF

published on 05/23/2025 at 08:35, 8 months 23 days ago

Inventiva publie ses résultats financiers du premier trimestre 2025 : la trésorerie diminue

Résultats Financiers Essai Clinique Situation De Trésorerie Inventiva Lanifibranor
PRESS RELEASE

published on 05/23/2025 at 08:30, 8 months 23 days ago

Inventiva publie ses informations financières¹ du 1er trimestre 2025
Inventiva publie ses informations financières du 1er trimestre 2025, avec une trésorerie de 67,9 millions d'euros. Progrès notables en R&D et publications scientifiques récentes dévoilées

R&D Trésorerie Publications Scientifiques Inventiva Trimestre 2025
PRESS RELEASE

published on 05/23/2025 at 08:30, 8 months 23 days ago

Inventiva reports 2025 First Quarter Financial Information¹
Inventiva reports €67.9 million in cash and cash equivalents for Q1 2025. Forecasted funds to support operations until Q3 2026. Key milestones include Phase 3 trial results expected in late 2026

Financial Information Inventiva Q1 2025 Cash Equivalents NATiV3 Trial
BRIEF

published on 05/22/2025 at 14:05, 8 months 23 days ago

Inventiva dévoile les détails de son programme de rachat d'actions

Rachat D'actions Réduction De Capital Stabilité Du Marché Accord De Liquidité Options D'achat D'actions Des Employés
BRIEF

published on 05/22/2025 at 14:05, 8 months 23 days ago

Inventiva Unveils Details of Share Repurchase Program

Share Repurchase Liquidity Agreement Capital Reduction Market Stability Employee Stock Options
PRESS RELEASE

published on 05/22/2025 at 14:00, 8 months 23 days ago

Description of the Share Repurchase Program Covered by the Liquidity Agreement with Kepler Chevreux
Inventiva implements share repurchase program with Kepler Chevreux under liquidity agreement approved by Ordinary General Meeting. Program details and objectives announced for 18-month period

Liquidity Agreement Ordinary General Meeting Share Repurchase Program Inventiva Kepler Chevreux

Accesswire

Published on 02/14/2026 at 01:00, 1 day 9 hours ago

Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:30, 1 day 12 hours ago

Norse Gold Corp. Announces New Director
Published on 02/13/2026 at 22:15, 1 day 12 hours ago

Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 1 day 16 hours ago

Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 1 day 20 hours ago

Datametrex Received $500,000 Purchase Order For Data Centre Solutions

View all ACCESSWIRE

EQS Group

Published on 02/15/2026 at 09:35, 1 hour 5 minutes ago

Canary Islands at the Berlinale European Film Market with more than 40 professionals from the islands
Published on 02/14/2026 at 16:30, 18 hours 10 minutes ago

Milano Cortina 2026 Licensed Candies Released Globally
Published on 02/14/2026 at 06:05, 1 day 4 hours ago

The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 1 day 15 hours ago

Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 1 day 15 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 02/14/2026 at 07:00, 1 day 3 hours ago

Groupe DLSI - Chiffre d'affaires 2025
Published on 02/13/2026 at 18:05, 1 day 16 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 1 day 16 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 1 day 16 hours ago

Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 1 day 16 hours ago

Nombre total d'actions et droits de vote - janvier 2026

View all LES ECHOS COMFI WIRE